Clinical Trial Update: Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid [Phase 3]

View source ↗

Summary

A Phase 3 trial update examining the efficacy and safety of adding linagliptin to metformin in adults with type 2 diabetes, including metformin 500 or 1000 mg t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucophage (metformin)
• Tradjenta (Linagliptin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2012-07-18